# Amneal Pharmaceuticals, Inc.: Form 8-K, filed Dec 16, 2019

- Company: [Amneal Pharmaceuticals, Inc.](/companies/amrx.md) (CIK 1723128)
- Form: 8-K
- Filed: 2019-12-16
- Accepted by EDGAR: Dec 16, 2019, 16:50 ET
- Period: 2019-12-14
- Accession: 0001193125-19-315267
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1723128/000119312519315267/d843477d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723128/000119312519315267/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723128/000119312519315267/d843477d8k.htm

Filed Dec 16, 2019.
Source: SEC EDGAR, the filing index for accession 0001193125-19-315267. Last ingested by Listed: Nov 10, 2026, 02:45 ET. No prices; not investment advice.
